botulinum toxin type a

The drug is used to treat various neurological disorders (e.g., muscle spasticity in children and adults, chronic migraine, blepharospasm), bladder function disorders (overactivity and urinary incontinence), as well as for the correction of facial wrinkles and the treatment of excessive sweating (hyperhidrosis).

Form: powder for injection solution

ATC: M03AX01

Manufacturer: Allergan Pharmaceuticals Ireland

The drug is used to treat various neurological disorders (e.g., muscle spasticity in children and adults, blepharospasm, cervical dystonia, chronic migraine), bladder function disorders (overactivity and urinary incontinence), as well as for the treatment of hyperhidrosis (excessive sweating) and the correction of certain types of facial wrinkles.

Form: powder for injection solution

ATC: M03AX01

Manufacturer: Allergan Pharmaceuticals Ireland

The drug is used for the temporary improvement of appearance in moderate to severe vertical wrinkles between the eyebrows (glabellar lines) that have a significant psychological impact on adults up to 65 years of age.

Form: powder for injection solution

ATC: M03AX01

Manufacturer: Devron Pharmaceutical Co. Ltd

The drug is used for the temporary reduction of facial wrinkles (between the eyebrows, around the eyes, and on the forehead) in adults up to 65 years of age. It is also indicated for the treatment of blepharospasm, spasmodic torticollis, and arm muscle spasticity.

Form: powder for injection solution

ATC: M03AX01

Manufacturer: Merz Pharma GmbH & Co. KGaA (manufacturing of unpackaged product, in-process quality control testing, cell-based quantification, quantitative determination of Botulinum neurotoxin Clostridium Botulinum type A (ELISA), primary packaging; secondary packaging, batch release)

The drug is used for the temporary reduction of facial wrinkles (between the eyebrows, around the eyes, and on the forehead) in adults up to 65 years of age. It is also prescribed for the treatment of blepharospasm, cervical dystonia, and muscle spasticity in the arm.

Form: powder for injection solution

ATC: M03AX01

Manufacturer: Merz Pharma GmbH & Co. KGaA (manufacturing of unpackaged product, in-process quality control testing, cell-based assay, quantitative determination of Botulinum neurotoxin Clostridium Botulinum type A (ELISA), primary packaging; secondary packaging, batch release)